激活素A-肌肉生长抑制素-卵泡抑素系统与炎性肌病疾病活动相关
该研究纳入94例特发性炎性肌病(IIM)患者和162例健康对照,检测循环及骨骼肌中肌肉生长抑制素、卵泡抑素、激活素A和TGF-β1水平。结果显示IIM患者循环肌肉生长抑制素降低、卵泡抑素和激活素A升高,且肌肉生长抑制素与医生评估的肌肉疾病活动度(MDA)负相关,卵泡抑素与MDA正相关。骨骼肌中卵泡抑素和FSTL3表达升高,而ALK4、SMAD3和atrogin-1表达降低。
要点
- IIM患者循环肌肉生长抑制素降低、卵泡抑素和激活素A升高。
- 肌肉生长抑制素与MDA负相关,卵泡抑素与MDA正相关。
- IIM骨骼肌中卵泡抑素和FSTL3表达升高,ALK4、SMAD3和atrogin-1表达降低。
核心结论
- IIM患者循环中肌肉生长抑制素降低、卵泡抑素和激活素A升高,骨骼肌中肌肉生长抑制素通路信号组分表达减弱。
研究设计与样本
- 研究纳入94例IIM患者和162例健康对照,其中20例IIM患者和28例健康对照接受肌肉活检。
- 采用ELISA检测循环肌肉生长抑制素、卵泡抑素、激活素A和TGF-β1浓度,实时PCR检测肌肉组织中相关基因表达。
主要发现
- IIM患者循环肌肉生长抑制素中位数1817 pg/ml,低于健康对照的2659 pg/ml(P=0.003)。
- IIM患者循环卵泡抑素中位数1319 pg/ml,高于健康对照的1055 pg/ml(P=0.028)。
- IIM患者循环激活素A中位数414 pg/ml,高于健康对照的309 pg/ml(P=0.0005)。
- 肌肉生长抑制素与MDA负相关(r=-0.289,P=0.015),与八块肌肉徒手肌力测试正相关(r=0.366,P=0.002)。
- 卵泡抑素与MDA正相关(r=0.235,P=0.047)。
关键数值与推荐
- IIM肌肉组织较对照卵泡抑素表达升高(P=0.003)、FSTL3表达升高(P=0.008)、ALK4表达降低(P=0.034)、SMAD3表达降低(P=0.023)、atrogin-1表达降低(P=0.0009)。
临床怎么用
- 循环肌肉生长抑制素、卵泡抑素和激活素A或可作为评估IIM疾病活动度的潜在生物标志物。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to investigate the systemic and skeletal muscle levels of atrophy-associated myokines in patients with idiopathic inflammatory myopathies (IIM) and their association with clinical characteristics of myositis. METHODS: A total of 94 IIM patients and 162 healthy controls were recruited. Of those, 20 IIM patients and 28 healthy controls underwent a muscle biopsy. Circulating concentrations of myostatin, follistatin, activin A and TGF-β1 were assessed by ELISA. The expression of myokines and associated genes involved in the myostatin signalling pathway in muscle tissue was determined by real-time PCR. RESULTS: We report decreased levels of circulating myostatin (median 1817 vs 2659 pg/ml; P = 0.003) and increased follistatin (1319 vs 1055 pg/ml; P = 0.028) in IIM compared with healthy controls. Activin A levels were also higher in IIM (414 vs 309 pg/ml; P = 0.0005) compared with controls. Myostatin was negatively correlated to muscle disease activity assessed by physician on visual analogue scale (MDA) (r = -0.289, P = 0.015) and positively to manual muscle testing of eight muscles (r = 0.366, P = 0.002). On the other hand, follistatin correlated positively with MDA (r = 0.235, P = 0.047). Gene expression analysis showed higher follistatin (P = 0.003) and myostatin inhibitor follistatin-like 3 protein (FSTL3) (P = 0.008) and lower expression of activin receptor type 1B (ALK4) (P = 0.034), signal transducer SMAD3 (P = 0.023) and atrophy marker atrogin-1 (P = 0.0009) in IIM muscle tissue compared with controls. CONCLUSION: This study shows lower myostatin and higher follistatin levels in circulation and attenuated expression of myostatin pathway signalling components in skeletal muscle of patients with myositis, a newly emerging pattern of the activin A-myostatin-follistatin system in muscle wasting diseases.
引用
- Vernerová L, Horváthová V, Kropáčková T, et al. Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies. Rheumatology (Oxford). 2020. PMID: 31990347. doi:10.1093/rheumatology/kez651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。